Cargando…

High-dimensional single-cell analysis reveals the immune signature of narcolepsy

Narcolepsy type 1 is a devastating neurological sleep disorder resulting from the destruction of orexin-producing neurons in the central nervous system (CNS). Despite its striking association with the HLA-DQB1*06:02 allele, the autoimmune etiology of narcolepsy has remained largely hypothetical. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Felix J., Bernard-Valnet, Raphaël, Quériault, Clémence, Mrdjen, Dunja, Weber, Lukas M., Galli, Edoardo, Krieg, Carsten, Robinson, Mark D., Nguyen, Xuan-Hung, Dauvilliers, Yves, Liblau, Roland S., Becher, Burkhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110028/ https://www.ncbi.nlm.nih.gov/pubmed/27821550 http://dx.doi.org/10.1084/jem.20160897

Ejemplares similares

Histamine in murine narcolepsy: What do genetic and immune models tell us?
por: Melzi, Silvia, et al.
Publicado: (2021)

Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019)

GM-CSF and CXCR4 Define a T Helper Cell Signature in Multiple Sclerosis
por: Galli, Edoardo, et al.
Publicado: (2019)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023)

Executive Control of Attention in Narcolepsy
por: Bayard, Sophie, et al.
Publicado: (2012)

Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy
por: Bayard, Sophie, et al.
Publicado: (2013)

Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
por: Dauvilliers, Yves A., et al.
Publicado: (2014)

Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)

Differences in Brain Morphological Findings between Narcolepsy with and without Cataplexy
por: Nakamura, Masaki, et al.
Publicado: (2013)

Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)

Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy
por: Deloumeau, Aude, et al.
Publicado: (2010)

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017)

Clinical and polysomnographic course of childhood narcolepsy with cataplexy
por: Pizza, Fabio, et al.
Publicado: (2013)

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture?
por: Zhang, Min, et al.
Publicado: (2020)

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2017)

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets
por: Nowicka, Malgorzata, et al.
Publicado: (2019)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy
por: Plazzi, Giuseppe, et al.
Publicado: (2011)

Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells
por: Lecendreux, Michel, et al.
Publicado: (2017)

CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
por: Barateau, Lucie, et al.
Publicado: (2020)

Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
por: Seifinejad, Ali, et al.
Publicado: (2023)

Narcolepsy
por: Maclachlan, T. Kay
Publicado: (1930)

Narcolepsy
Publicado: (1929)

Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis
por: Dauvilliers, Y., et al.
Publicado: (2016)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
por: Watson, Nathaniel F., et al.
Publicado: (2021)

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
por: Ollila, Hanna M., et al.
Publicado: (2023)

Misdiagnosis of narcolepsy
por: Dunne, Laura, et al.
Publicado: (2016)

Idiopathic Narcolepsy
Publicado: (1927)

Genetics of narcolepsy
por: Miyagawa, Taku, et al.
Publicado: (2019)

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
por: Evans, Rebecca, et al.
Publicado: (2022)

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
por: Dauvilliers, Yves, et al.
Publicado: (2023)

Narcolepsy: a review
por: Akintomide, Gbolagade Sunmaila, et al.
Publicado: (2011)

A Case of Narcolepsy
por: Rogers, Bertram M. H.
Publicado: (1907)

Narcolepsy type 1
por: Swarnakar, Rajesh, et al.
Publicado: (2019)

A Case of Narcolepsy
por: Rogers, Bertram M. H.
Publicado: (1907)

Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
por: Stephansen, Jens B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_84ek6ue55koqjq58965n6rjc99